Clik here to view.
Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review...
The report “Alopecia – Pipeline Review, H1 2015″ provides comprehensive information on the therapeutic development for Alopecia. Alopecia is the loss of hair. Alopecia areata and androgenetic alopecia...
View ArticleClik here to view.
11th Annual Children’s Alopecia Project Spring Fundraiser
On Friday, March 13th the Children’s Alopecia Project will host its 11th Annual Spring Fundraiser at the Crowne Plaza Reading. The 1st CAP Blues Spectacular! Featuring Jessy Carolina & The Hot...
View ArticleClik here to view.
The Androgenic Alopecia Protective Effects of Forsythiaside-A
The Androgenic Alopecia Protective Effects of Forsythiaside-A and the Molecular Regulation in a Mouse Model This study examined the inhibitory effect of forsythiaside-A, a natural substance derived...
View ArticleClik here to view.
Cancer drug found effective in treating autoimmune baldness
Researchers from Israel’s Hadassah Medical Center who gave a patient a cancer drug that is being studied as a possible treatment for rheumatoid arthritis discovered that the drug is also effective in...
View ArticleClik here to view.
Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
Background Alopecia areata (AA) is one of the most common autoimmune diseases and targets the hair follicles, with high impact on the quality of life and self-esteem of patients due to hair loss....
View ArticleClik here to view.
Lower zinc levels linked to more severe alopecia
Lower serum zinc levels are associated with worse outcomes in patients with alopecia areata, according to a study published online July 3 in the International Journal of Dermatology. Researchers found...
View ArticleKerastem Receives Conditional Approval from FDA for Alopecia Trial
Kerastem Technologies announce that the Company has received notice of conditional approval from the U.S. FDA Center For Biologics Evaluation and Research (CBER) Office of Cellular, Tissue and Gene...
View ArticleAlopecia Global Clinical Trials Review, H1, 2015
Recent research into the alopecia global clinical trials review for 2015 examined in new market research report Clinical trial report, “Alopecia Global Clinical Trials Review, H1, 2015″ provides an...
View ArticleSamumed Phase II Study For A Potential Treatment Of Alopecia
Samumed Announces Increases In Both Hair Count And Hair Density Observed In Its Phase II Study For A Potential Treatment Of Androgenetic Alopecia (AGA) Samumed, LLC, a leader in tissue regeneration,...
View ArticleEurope Alopecia Areata Market Highlights 2015
Europe Alopecia Areata Market Highlights 2015 Research and Markets has announced the addition of the “Europe Alopecia Areata Market Highlights – 2015” report to their offering. The research helps...
View ArticleAlopecia Treatment Market
Alopecia (Hair Loss)Treatment Market: Global Industry Analysis and Forecast 2016 – 2022 Alopecia is a term used to describe excessive hair damage under certain medical conditions or dietary issues....
View ArticleSimvastatin/Ezetimibe Not Beneficial in Alopecia Areata
Simvastatin/Ezetimibe Not Beneficial in Alopecia Areata Simvastatin/ezetimibe does not appear to be beneficial for severe alopecia areata (AA) in a sample of 20 patients, according to a letter to the...
View ArticleCTP-543 for Treatment of Alopecia Areata
Concert Pharmaceuticals Unveils CTP-543 for Treatment of Alopecia Areata Concert Pharmaceuticals, Inc today announced its next product candidate, CTP-543, for the treatment of alopecia areata. Alopecia...
View ArticleAlopecia Clinical Review
Alopecia Clinical Review, Market Growth, Segment, Trends and Forecast 2016 – 2020 “Alopecia Worldwide 2016 Clinical Trials Review, H2″ includes an complete overview of Alopecia scenario. This Alopecia...
View ArticleNew Treatment for Alopecia Areata
Concert Pharmaceuticals Initiates Phase 1 Trial of CTP-543 as a New Treatment for Alopecia Areata Concert Pharmaceuticals, Inc today announced that it has initiated its Phase 1 clinical program for...
View ArticleClik here to view.
Alopecia Market Projected to be 11.8 Billion By 2024
Alopecia Market Projected to be Worth $11.8 Billion By 2024 The global alopecia market was valued at over USD 7.3 billion in 2015. Key factors attributing to the growth of the alopecia market include...
View ArticleClik here to view.
Asia Pacific Alopecia Treatment Market
Asia Pacific Alopecia Treatment Market to Reach US$ 2,655.9 Mn by 2024, Driven by Increasing Prevalence of Chemotherapy Induced Alopecia By PMR According to a latest market report published by...
View ArticleAlopecia Awareness Week
Alopecia Awareness Week: How wigs can help children with the condition feel more confident STELLA Hammet was five years old when her hair started falling out. The 12-year-old from Melbourne has...
View ArticleClik here to view.
Alopecia Treatment Market Significant Profits Estimated to be Generated by 2022
Alopecia (Hair Loss)Treatment Market Significant Profits Estimated to be Generated by 2022 Alopecia is a term used to describe excessive hair damage under certain medical conditions or dietary issues....
View ArticlePediatric Alopecia Areata Severity Linked to Serum Vitamin D
Pediatric Alopecia Areata Severity Linked to Serum Vitamin D For pediatric patients with alopecia areata, vitamin D is negatively correlated with disease severity, number of patches, and disease...
View Article
